Estrogen requirements in girls with Turner syndrome; How low is enough for initiating puberty and uterine development?

Gynecological Endocrinology

Volumn 28, Issue 2, 2012, Pages 130-133

  Kim, Na Young ^a   Lee, Dong Yun ^a   Kim, Min Jae ^a   Yoon, Byung Koo ^a   Choi, Dooseok ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Estrogen replacement therapy; Turner syndrome; Uterine development

Indexed keywords

CALCIUM; ESTRADIOL VALERATE; MEDROXYPROGESTERONE ACETATE; VITAMIN D;

ADOLESCENT; ARTICLE; BONE DENSITY; BREAST DEVELOPMENT; CLINICAL ARTICLE; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HUMAN; MEDICAL RECORD REVIEW; ORGANOGENESIS; PREMATURE OVARIAN FAILURE; PRIORITY JOURNAL; PUBERTY; TURNER SYNDROME; UTERINE DEVELOPMENT;

ADOLESCENT; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HORMONES; HUMANS; PUBERTY; TURNER SYNDROME; UTERUS;

EID: 84862953148     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.588752     Document Type: Article

References (13)

1. Birkebaek NH, Crüger D, Hansen J, Nielsen J, Bruun-Petersen G. Fertility and pregnancy outcome in Danish women with Turner syndrome. Clin Genet 2002;61:35-39. (Pubitemid 36372600)
2. Hovatta O. Pregnancies in women with Turner's syndrome. Ann Med 1999;31:106-110. (Pubitemid 29209865)
3. Lippe B. Turner syndrome. Endocrinol Metab Clin North Am 1991;20:121-152.
4. Abdalla HI, Baber R, Kirkland A, Leonard T, Power M, Studd JW. A report on 100 cycles of oocyte donation; factors affecting the outcome. Hum Reprod 1990;5:1018-1022.
5. Khastgir G, Abdalla H, Thomas A, Korea L, Latarche L, Studd J. Oocyte donation in Turner's syndrome: an analysis of the factors affecting the outcome. Hum Reprod 1997;12:279-285. (Pubitemid 27129387)
6. Li TC, Dockery P, Ramsewak SS, Klentzeris L, Lenton EA, Cooke ID. The variation of endometrial response to a standard hormone replacement therapy in women with premature ovarian failure. An ultrasonographic and histological study. Br J Obstet Gynaecol 1991;98:656-661.
7. Snajderova M, Mardesic T, Lebl J, Gerzova H, Teslik L, Zapletalova J; Czech National Study Group for HRT Optimization in Paediatric and Adolescent Endocrinology and Gynaecology. The uterine length in women with Turner syndrome reflects the postmenarcheal daily estrogen dose. Horm Res 2003;60:198-204.
8. Paterson WF, Hollman AS, Donaldson MD. Poor uterine development in Turner syndrome with oral oestrogen therapy. Clin Endocrinol (Oxf) 2002;56:359-365. (Pubitemid 34310014)
9. Doerr HG, Bettendorf M, Hauffa BP, Mehls O, Partsch CJ, Said E, Sander S, et al. Uterine size in women with Turner syndrome after induction of puberty with estrogens and long-term growth hormone therapy: results of the German IGLU Follow-up Study 2001. Hum Reprod 2005;20:1418-1421.
10. Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R, Hovatta O, et al.; Fifth International Symposium on Turner Syndrome. Recommendations for the diagnosis and management of Turner syndrome. J Clin Endocrinol Metab 2001;86:3061-3069. (Pubitemid 32673466)
11. McDonnell CM, Coleman L, Zacharin MR. A 3-year prospective study to assess uterine growth in girls with Turner's syndrome by pelvic ultrasound. Clin Endocrinol (Oxf) 2003;58:446-450. (Pubitemid 36390616)
12. Porcu E, Venturoli S, Fabbri R, Orsini LF, Sganga E, Brondelli L, Paradisi R, Flamigni C. Uterine development and endocrine relationships after menarche. Am J Obstet Gynecol 1989;161:174-177. (Pubitemid 19185771)
13. Hanton L, Axelrod L, Bakalov V, Bondy CA. The importance of estrogen replacement in young women with Turner syndrome. J Womens Health (Larchmt) 2003;12:971-977. (Pubitemid 38072415)